PL3781558T3 - Inhibitory funkcji płytek krwi i sposoby ich zastosowania - Google Patents
Inhibitory funkcji płytek krwi i sposoby ich zastosowaniaInfo
- Publication number
- PL3781558T3 PL3781558T3 PL19722359.7T PL19722359T PL3781558T3 PL 3781558 T3 PL3781558 T3 PL 3781558T3 PL 19722359 T PL19722359 T PL 19722359T PL 3781558 T3 PL3781558 T3 PL 3781558T3
- Authority
- PL
- Poland
- Prior art keywords
- inhibitors
- methods
- same
- platelet function
- platelet
- Prior art date
Links
- 239000003112 inhibitor Substances 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
- C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
- C07D249/10—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D249/12—Oxygen or sulfur atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Diabetes (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Hematology (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862659024P | 2018-04-17 | 2018-04-17 | |
| PCT/US2019/027881 WO2019204447A1 (en) | 2018-04-17 | 2019-04-17 | Inhibitors of platelet function and methods for use of the same |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL3781558T3 true PL3781558T3 (pl) | 2023-05-02 |
Family
ID=66429584
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL19722359.7T PL3781558T3 (pl) | 2018-04-17 | 2019-04-17 | Inhibitory funkcji płytek krwi i sposoby ich zastosowania |
Country Status (9)
| Country | Link |
|---|---|
| US (3) | US11498905B2 (pl) |
| EP (1) | EP3781558B1 (pl) |
| CN (1) | CN113015725B (pl) |
| CA (1) | CA3134447A1 (pl) |
| DK (1) | DK3781558T3 (pl) |
| ES (1) | ES2942214T3 (pl) |
| HU (1) | HUE062236T2 (pl) |
| PL (1) | PL3781558T3 (pl) |
| WO (1) | WO2019204447A1 (pl) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2026085283A1 (en) | 2024-10-16 | 2026-04-23 | Regents Of The University Of Michigan | Cs585 (5-((4-((5,6-diphenylpyrazin-2-yl)(isopropyl)amino)butyl)thio)-2,4-dihydro-3h-1,2,4-triazol-3-one) for use in treating inflammatory and autoimmune disorders |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP5504259B2 (ja) | 2008-05-19 | 2014-05-28 | メルク・シャープ・アンド・ドーム・コーポレーション | 第ｉｘａ因子阻害剤としての複素環式化合物 |
| TW201319068A (zh) * | 2011-08-05 | 2013-05-16 | 必治妥美雅史谷比公司 | 作為ｘｉａ因子抑制劑之環狀ｐ１接合劑 |
| CN107849026B (zh) * | 2015-07-29 | 2021-01-01 | 百时美施贵宝公司 | 携带烷基或环烷基p2′部分的因子xia大环抑制剂 |
| EP3475442B1 (en) | 2016-06-23 | 2024-10-23 | The Regents of The University of Michigan | 12(s)-hydroxyeicosatrienoic acid compounds and their use as therapeutic agents |
-
2019
- 2019-04-17 HU HUE19722359A patent/HUE062236T2/hu unknown
- 2019-04-17 CN CN201980040718.4A patent/CN113015725B/zh active Active
- 2019-04-17 PL PL19722359.7T patent/PL3781558T3/pl unknown
- 2019-04-17 US US17/047,422 patent/US11498905B2/en active Active
- 2019-04-17 ES ES19722359T patent/ES2942214T3/es active Active
- 2019-04-17 CA CA3134447A patent/CA3134447A1/en active Pending
- 2019-04-17 WO PCT/US2019/027881 patent/WO2019204447A1/en not_active Ceased
- 2019-04-17 DK DK19722359.7T patent/DK3781558T3/da active
- 2019-04-17 EP EP19722359.7A patent/EP3781558B1/en active Active
-
2022
- 2022-10-19 US US17/969,519 patent/US12269805B2/en active Active
-
2025
- 2025-03-19 US US19/084,150 patent/US20260035352A1/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| HUE062236T2 (hu) | 2023-10-28 |
| US20260035352A1 (en) | 2026-02-05 |
| DK3781558T3 (da) | 2023-04-03 |
| CA3134447A1 (en) | 2019-10-24 |
| US12269805B2 (en) | 2025-04-08 |
| ES2942214T3 (es) | 2023-05-30 |
| WO2019204447A1 (en) | 2019-10-24 |
| CN113015725A (zh) | 2021-06-22 |
| CN113015725B (zh) | 2024-08-13 |
| EP3781558A1 (en) | 2021-02-24 |
| EP3781558B1 (en) | 2023-03-01 |
| US20210363113A1 (en) | 2021-11-25 |
| US20230140210A1 (en) | 2023-05-04 |
| US11498905B2 (en) | 2022-11-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL290399A (en) | kras g12c inhibitors and methods of using them | |
| IL287223B1 (en) | kras g12c inhibitors and methods of using them | |
| IL272512A (en) | Inhibitors of kras g12c and methods of using the same | |
| IL282350A (en) | Bernani-RGMC inhibitors and their use | |
| IL270330B (en) | Beta-lactamase inhibitors and their uses | |
| IL261606A (en) | Inhibitors of transfected menin-mll and methods of use | |
| ZA201905677B (en) | Glycan-interacting compounds and methods of use | |
| IL274504A (en) | 2ACSS inhibitors and methods of their use | |
| IL279475A (en) | Actonucleotidase inhibitors and methods of using them | |
| IL267291B (en) | Actonucleotidase inhibitors and methods of using them | |
| IL277600A (en) | AXLkinase inhibitors and their use | |
| IL283387A (en) | Diarylhydantoin compounds and methods of use thereof | |
| PL3621615T3 (pl) | Inhibitory regulujące sygnał apoptozy kinazy 1 i sposoby ich stosowania | |
| PT3621694T (pt) | Inibidores de lrrc33 e sua utilização | |
| GB2589398B (en) | Compounds and methods of use | |
| IL280408A (en) | CDK inhibitors and uses thereof | |
| HUE062236T2 (hu) | Vérlemezke funkció inhibitorok és eljárás azok alkalmazására | |
| IL279071A (en) | Multipurpose holding device and method for using it | |
| HK40049706A (en) | Ectonucleotidase inhibitors and methods of use thereof | |
| GB201908573D0 (en) | Compounds and methods of use | |
| HK40059660A (en) | Rgmc-selective inhibitors and use thereof | |
| HK40045754A (en) | B7-h7-binding agents and methods of use thereof | |
| HK40046587A (zh) | Axl激酶抑制剂及其用途 | |
| GB201810835D0 (en) | Methods of use | |
| HK40017064A (en) | Glycan-interacting compounds and methods of use |